Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Bacterial cell wall products like lipopolysaccharide (LPS) and muramyl dipeptide (MDP) are potent immunomodulators.
• Understanding their effects on immune cell receptor expression is crucial for deciphering immune responses and toxicity.
• Key receptors involved in antigen presentation, costimulation, and cell activation are critical targets for immunomodulation.

Purpose of the Study:

• To investigate the effects of LPS and MDP on the expression of key immune receptors on human whole blood cells.
• To compare the immunomodulatory potency of LPS and MDP.
• To elucidate the mechanisms underlying LPS- and MDP-induced immune cell activation.

Main Methods:

• Human whole blood was incubated with LPS (100 ng/ml) and MDP (100 ng/ml).
• Flow cytometry was used to analyze the surface expression of various receptors, including HLA-DR, CD18, CD54 (ICAM-1), CD86, CD28, CD49d/CD29, CD106 (VCAM-1), and CD69.
• Blocking studies using anti-CD18 monoclonal antibodies were performed to investigate the role of CD18 in LPS/MDP-induced signaling.

Main Results:

• Both LPS and MDP increased surface expression of HLA-DR, CD18, CD54 (ICAM-1), and CD86 on monocytes.
• LPS, but not MDP, increased HLA-DR expression on lymphocytes after 18 hours.
• LPS induced CD69 expression on monocytes (CD14-dependent, CD18-independent) and various leukocyte subsets (T cells, B cells, NK cells), while MDP did not.

Conclusions:

• LPS exhibits a stronger immunomodulatory effect compared to MDP.
• The observed differences in immune cell activation may partially explain the differential toxicity of LPS and MDP.
• LPS-induced CD69 expression is mediated through a CD14-dependent, CD18-independent pathway.